Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits
dc.contributor.author | Koike, T | |
dc.contributor.author | Koike, Y | |
dc.contributor.author | Yang, D | |
dc.contributor.author | Guo, Y | |
dc.contributor.author | Rom, O | |
dc.contributor.author | Song, J | |
dc.contributor.author | Xu, J | |
dc.contributor.author | Chen, Y | |
dc.contributor.author | Wang, Y | |
dc.contributor.author | Zhu, T | |
dc.contributor.author | Garcia-Barrio, MT | |
dc.contributor.author | Fan, J | |
dc.contributor.author | Chen, YE | |
dc.contributor.author | Zhang, J | |
dc.coverage.spatial | Ireland | |
dc.date.accessioned | 2022-10-05T14:45:03Z | |
dc.date.available | 2022-10-05T14:45:03Z | |
dc.date.issued | 2021-01-01 | |
dc.identifier.issn | 0021-9150 | |
dc.identifier.issn | 1879-1484 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/33296791 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/174890 | en |
dc.description.abstract | Background and aims: Apolipoprotein A-II (apoAII) is the second major apolipoprotein of the high-density lipoprotein (HDL) particle, after apoAI. Unlike apoAI, the biological and physiological functions of apoAII are unclear. We aimed to gain insight into the specific roles of apoAII in lipoprotein metabolism and atherosclerosis using a novel rabbit model. Methods: Wild-type (WT) rabbits are naturally deficient in apoAII, thus their HDL contains only apoAI. Using TALEN technology, we replaced the endogenous apoAI in rabbits through knock-in (KI) of human apoAII. The newly generated apoAII KI rabbits were used to study the specific function of apoAII, independent of apoAI. Results: ApoAII KI rabbits expressed exclusively apoAII without apoAI, as confirmed by RT-PCR and Western blotting. On a standard diet, the KI rabbits exhibited lower plasma triglycerides (TG, 52%, p < 0.01) due to accelerated clearance of TG-rich particles and higher lipoprotein lipase activity than the WT littermates. ApoAII KI rabbits also had higher plasma HDL-C (28%, p < 0.05) and their HDL was rich in apoE, apoAIV, and apoAV. When fed a cholesterol-rich diet for 16 weeks, apoAII KI rabbits were resistant to diet-induced hypertriglyceridemia and developed significantly less aortic atherosclerosis compared to WT rabbits. HDL isolated from rabbits with apoAII KI had similar cholesterol efflux capacity and anti-inflammatory effects as HDL isolated from the WT rabbits. Conclusions: ApoAII KI rabbits developed less atherosclerosis than WT rabbits, possibly through increased plasma HDL-C, reduced TG and atherogenic lipoproteins. These results suggest that apoAII may serve as a potential target for the treatment of atherosclerosis. | |
dc.format.medium | Print-Electronic | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.subject | ApoAII | |
dc.subject | Atherosclerosis | |
dc.subject | HDL | |
dc.subject | Knock-in | |
dc.subject | Rabbit | |
dc.subject | Animals | |
dc.subject | Apolipoprotein A-I | |
dc.subject | Apolipoprotein A-II | |
dc.subject | Atherosclerosis | |
dc.subject | Cholesterol | |
dc.subject | Humans | |
dc.subject | Lipoproteins, HDL | |
dc.subject | Rabbits | |
dc.title | Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits | |
dc.type | Article | |
dc.identifier.pmid | 33296791 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174890/2/2021-apoaii-rabbit.pdf | |
dc.identifier.doi | 10.1016/j.atherosclerosis.2020.11.028 | |
dc.identifier.doi | https://dx.doi.org/10.7302/6519 | |
dc.identifier.source | Atherosclerosis | |
dc.description.version | Published version | |
dc.date.updated | 2022-10-05T14:44:59Z | |
dc.identifier.orcid | 0000-0003-4718-8234 | |
dc.identifier.orcid | 0000-0002-4470-6350 | |
dc.identifier.orcid | 0000-0003-2449-8651 | |
dc.identifier.orcid | 0000-0002-3334-9159 | |
dc.identifier.orcid | 0000-0003-2357-7825 | |
dc.identifier.orcid | 0000-0001-5161-4705 | |
dc.identifier.volume | 316 | |
dc.identifier.startpage | 32 | |
dc.identifier.endpage | 40 | |
dc.identifier.name-orcid | Koike, T; 0000-0003-4718-8234 | |
dc.identifier.name-orcid | Koike, Y; 0000-0002-4470-6350 | |
dc.identifier.name-orcid | Yang, D; 0000-0003-2449-8651 | |
dc.identifier.name-orcid | Guo, Y; 0000-0002-3334-9159 | |
dc.identifier.name-orcid | Rom, O | |
dc.identifier.name-orcid | Song, J | |
dc.identifier.name-orcid | Xu, J | |
dc.identifier.name-orcid | Chen, Y | |
dc.identifier.name-orcid | Wang, Y | |
dc.identifier.name-orcid | Zhu, T | |
dc.identifier.name-orcid | Garcia-Barrio, MT | |
dc.identifier.name-orcid | Fan, J | |
dc.identifier.name-orcid | Chen, YE; 0000-0003-2357-7825 | |
dc.identifier.name-orcid | Zhang, J; 0000-0001-5161-4705 | |
dc.working.doi | 10.7302/6519 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.